Package 51991-074-01
Brand: ascomp with codeine
Generic: butalbital, aspirin, caffeine and codeine phosphatePackage Facts
Identity
Package NDC
51991-074-01
Digits Only
5199107401
Product NDC
51991-074
Description
100 CAPSULE in 1 BOTTLE, PLASTIC (51991-074-01)
Marketing
Marketing Status
Brand
ascomp with codeine
Generic
butalbital, aspirin, caffeine and codeine phosphate
Sample Package
No
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a41a61f0-e530-4fb5-8198-bdc866219e33", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175693", "M0002177", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["R16CO5Y76E", "KHS0AZ4JVK", "3G6A5W338E", "GSL05Y1MN6"], "rxcui": ["994237", "994239"], "spl_set_id": ["243a6aea-0f48-42a9-a85e-ff247ab94336"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Barbiturates [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Barbiturate [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["Breckenridge Pharmaceutical, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (51991-074-01)", "package_ndc": "51991-074-01", "marketing_start_date": "20090501"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE, PLASTIC (51991-074-05)", "package_ndc": "51991-074-05", "marketing_start_date": "20090501"}], "brand_name": "Ascomp with Codeine", "product_id": "51991-074_a41a61f0-e530-4fb5-8198-bdc866219e33", "dosage_form": "CAPSULE", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Barbiturate [EPC]", "Barbiturates [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Full Opioid Agonists [MoA]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Opioid Agonist [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "51991-074", "dea_schedule": "CIII", "generic_name": "Butalbital, Aspirin, Caffeine and Codeine Phosphate", "labeler_name": "Breckenridge Pharmaceutical, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Ascomp with Codeine", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}, {"name": "BUTALBITAL", "strength": "50 mg/1"}, {"name": "CAFFEINE", "strength": "40 mg/1"}, {"name": "CODEINE PHOSPHATE", "strength": "30 mg/1"}], "application_number": "ANDA075231", "marketing_category": "ANDA", "marketing_start_date": "20090501", "listing_expiration_date": "20271231"}